Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS
Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT

Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS

Antibiotic :: Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS

Antibiotic :: Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Applications (ANDA) to market its generic versions of Abbott's antibiotic Omnicef? (Cefdinir) Capsules, 300 mg, and for Oral Suspension, 125 mg/5 mL and 250 mg/5 mL. Teva has commenced shipment of these products.

Omnicef? Capsules and Omnicef? for Oral Suspension had annual sales of approximately $325 million and $533 million, respectively, in the U.S. based on IMS sales data.

Teva is currently in patent litigation concerning this product in the United States District Court for the Northern District of Illinois. A suit was brought against Teva in March 2007 involving Abbott's U.S. Patent No. 4,935,507.

On May 3, 2007, the District Court denied Abbott's request for a preliminary injunction against Teva with respect to its cefdinir products. The Court found that Abbott had not proven a likelihood of success on their allegations of infringement of Teva's products.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.

(Antibiotic :: Teva Announces Approval and Shipment of Generic Omnicef Capsules and POS published at SpiritIndia on Monday, May 14, 2007)

Search more information on Antibiotic

Recently posted related articles on Antibiotic :

  1. Antibiotic :: Predictors of inappropriate antibiotic prescribing among primary care physicians
  2. Antibiotic :: GSK & Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics
  3. Antibiotic :: Using evolution, UW team creates a template for many new therapeutic agents
  4. Antibiotic :: New insight into how antibiotics kill might make them deadlier
  5. Antibiotic :: Researchers discover new strategies for antibiotic resistance
  6. Antibiotic :: Frog plus frying pan equals better antibiotic
  7. MRSA :: UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
  8. Antibiotic :: Investigating antibiotic use in acute care patients
  9. Antibiotic :: Prescribing of antibiotics to children still at a level to cause drug resistance
  10. Antibiotic :: Researchers watch antibiotics, bacteria meet at atomic level

»»   GERD :: Teva Provides Update on Generic Aciphex Litigation
««   Cancer :: Teva Announces Tentative Approval of Generic Gemzar for Injection

Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com